课题基金 / 基金详情

Investigation of molecular mechanism involved in the aggressiveness of micropapillary component of adenocarcinoma of lung

Investigation of molecular mechanism involved in the aggressiveness of micropapillary component of adenocarcinoma of lung
肺腺癌微乳头成分侵袭性的分子机制研究
批准号:
21790369
负责人:
SHIMASAKI Miyako
金额:
$2.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2010

项目摘要

项目成果

SHIMASAKI Miyako的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Micropapillary component (MPC) has recently been accepted as a new prognostic factor of adenocarcinoma of the lung. Its molecular mechanism is, however, hardly elucidated. To establish a novel remedy for controlling advanced adenocarcinoma of the lung, molecular mechanism of the aggressiveness of micropapillary component was addressed in the present study. Cluster analyses of the gene expressions detected by cDNA microarray (Gene Chip, Affimetrix) separated adenocarcinomas with MPC from ordinary papillary adenocarcinomas. The adenocarcinomas with MPC were further divided into distinct two gene-expression patterns according to the tumor progression. While 30 genes showed significant different expressions between them, the upregulation of S100PA4 and down regulation of CXCL14 were demonstrated to be correlated with progression of MPC both at mRNA and protein levels. The present study also demonstrated the involvement of over-expression of aquaporin (AQP) 1 and 5 in the aggressive growth of adenocaricnoma with MPC, proposing the over-expression of AQP1 as an novel unfavorable prognostic factor of adenocarcinoma with MPC. In vitro studies using the transfection of AQP1 and siRNA of AQP1 gene showed increased cell motility and invasiveness of tumor cells through enhanced pseudopodia-formation. These results suggest that AQP1 and 5 may be a promising candidate molecules for gene-targeting therapy against adenocarcinoma of the lung.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Aquaporin as a novel player in cancer cell invasion
水通道蛋白作为癌细胞侵袭的新参与者
DOI: --
发表时间: 2010
期刊: Kanazawa Med J
影响因子: --
作者: [Yoshimichi Ueda]
通讯作者: Yoshimichi Ueda
Study on the molecular mechanism of prevention of steroid-induced osteonecrosis of the femur by intravenous administration of mesenchymal stem cells
  • 批准号:
    19K18510
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
  • 资助金额:
    $2.66万
  • 财政年份:
    2019
  • 负责人:
    SHIMASAKI Miyako
  • 依托单位: